Free tool
FAERS Monitor: Winrevair
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 761363 or its brand name (Winrevair, Sotatercept-Csrk). Reports on generic versions are filed under their own applications.
Reports
6,188
Serious
3,495
56% of reports
Hospitalization
2,598
Death reported
286
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- headache826
- dyspnoea698
- diarrhoea639
- fatigue548
- epistaxis537
- nausea507
- dizziness504
- haemoglobin increased315
- cough275
- dyspnoea exertional274
- vomiting256
- product dose omission issue253
- hypotension236
- weight decreased234
- pain in extremity233
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 40 |
| 2024 | 782 |
| 2025 | 2,268 |
| 2026 | 3,092 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,971 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| haemoglobin increasedSignal | 315 | 252.0 | 225.4 | 73,114 |
| dyspnoea exertionalSignal | 274 | 24.9 | 22.2 | 6,227 |
| epistaxisSignal | 537 | 24.6 | 22.7 | 12,075 |
| headacheSignal | 826 | 4.5 | 4.2 | 2,297 |
| dyspnoeaSignal | 698 | 4.2 | 3.9 | 1,740 |
| hypotensionSignal | 236 | 4.0 | 3.5 | 533 |
| dizzinessSignal | 504 | 3.4 | 3.2 | 889 |
| diarrhoeaSignal | 639 | 3.4 | 3.1 | 1,093 |
| coughSignal | 275 | 3.3 | 3.0 | 453 |
| product dose omission issueSignal | 253 | 2.9 | 2.6 | 323 |
| weight decreasedSignal | 234 | 2.9 | 2.5 | 283 |
| pain in extremitySignal | 233 | 2.7 | 2.4 | 249 |
| fatigueSignal | 548 | 2.4 | 2.2 | 460 |
| nauseaSignal | 507 | 2.2 | 2.0 | 334 |
| vomiting | 256 | 1.9 | 1.6 | 102 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.